Dr. Todd F. Dombrowski, MD

Dr. Dombrowski practices at Cheshire Medical Center in Keene, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Dombrowski's NPI, 1144481789, was assigned on June 17, 2008. Dr. Dombrowski graduated from American University of the Caribbean School of Medicine in 2006. Dr. Dombrowski's New Hampshire license number on file is 15291.

Dr. Dombrowski's primary practice is Cheshire Medical Center, at 580 Court Street, Keene, NH 03431 in Cheshire County. The practice phone is (603) 354-5400.

Dr. Dombrowski's primary practice is Cheshire Medical Center in Keene, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Dombrowski is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Dombrowski to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dombrowski practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Dombrowski's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Dombrowski is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dombrowski's licenses on file in 3 states: New Hampshire, Vermont and New York.

Dmand AI lists arteritis, arthritis, bursitis, carpal tunnel syndrome, chronic inflammatory bowel disease (IBD), fibromyalgia and chronic pain, fluid in a joint and gout among the conditions Dr. Dombrowski treats.

CMS data shows 1,216 Medicare services from Dr. Dombrowski across 6 procedure codes in 2024, for 409 Medicare patients. Medicare paid $66,864 for them.

CMS counts 409 Medicare patients who saw Dr. Dombrowski in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have arthritis, and 61% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dombrowski's median patient age at 65, with 73% women.

In 2024, Dr. Dombrowski wrote 4,330 Medicare Part D claims for 634 patients. 83% of them were for generic drugs. CMS names the drug for 4,052 of them, across 54 drugs with 11 or more claims each, at $4,017,488 in total drug cost. In 2023, CMS named 3,718 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Dombrowski for performance year 2024, reported as part of a group. Dr. Dombrowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dombrowski as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Dombrowski from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $85.

Dmand AI lists 3 awards for Dr. Dombrowski, most recently CMS Stage 1 EHR in 2012.

Dr. Dombrowski graduated from American University of the Caribbean School of Medicine in 2006. Dr. Dombrowski is a member of ACP, ACR, AMA and International Society of Clinical Densitometry.

Dr. Dombrowski is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.